Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

G vs CTSH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
G
Genpact Limited

Information Technology Services

TechnologyNYSE • BM
Market Cap$5.74B
5Y Perf.-6.0%
CTSH
Cognizant Technology Solutions Corporation

Information Technology Services

TechnologyNASDAQ • US
Market Cap$24.32B
5Y Perf.-3.2%

G vs CTSH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
G logoG
CTSH logoCTSH
IndustryInformation Technology ServicesInformation Technology Services
Market Cap$5.74B$24.32B
Revenue (TTM)$5.08B$21.41B
Net Income (TTM)$552M$2.23B
Gross Margin36.0%32.1%
Operating Margin14.8%15.7%
Forward P/E8.4x9.0x
Total Debt$1.76B$1.57B
Cash & Equiv.$854M$1.90B

G vs CTSHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

G
CTSH
StockMay 20May 26Return
Genpact Limited (G)10094.0-6.0%
Cognizant Technolog… (CTSH)10096.8-3.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: G vs CTSH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: G leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Cognizant Technology Solutions Corporation is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
G
Genpact Limited
The Growth Play

G carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 6.6%, EPS growth 9.8%, 3Y rev CAGR 5.1%
  • 41.3% 10Y total return vs CTSH's -0.5%
  • Lower volatility, beta 0.67, Low D/E 69.2%, current ratio 1.66x
Best for: growth exposure and long-term compounding
CTSH
Cognizant Technology Solutions Corporation
The Income Pick

CTSH is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 9 yrs, beta 0.75, yield 2.5%
  • Beta 0.75, yield 2.5%, current ratio 2.34x
  • 7.0% revenue growth vs G's 6.6%
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthCTSH logoCTSH7.0% revenue growth vs G's 6.6%
ValueG logoGLower P/E (8.4x vs 9.0x), PEG 0.57 vs 0.75
Quality / MarginsG logoG10.9% margin vs CTSH's 10.4%
Stability / SafetyG logoGBeta 0.67 vs CTSH's 0.75
DividendsCTSH logoCTSH2.5% yield, 9-year raise streak, vs G's 2.0%
Momentum (1Y)G logoG-30.6% vs CTSH's -32.3%
Efficiency (ROA)CTSH logoCTSH10.9% ROA vs G's 10.3%, ROIC 18.7% vs 17.2%

G vs CTSH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

GGenpact Limited
FY 2025
Consumer And Healthcare
100.0%$1.7B
CTSHCognizant Technology Solutions Corporation
FY 2025
Healthcare Segment
30.1%$6.3B
Financial Services
29.2%$6.2B
Products and Resources
25.0%$5.3B
Communication, Media and Technology
15.6%$3.3B

G vs CTSH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGLAGGINGCTSH

Income & Cash Flow (Last 12 Months)

G leads this category, winning 4 of 6 comparable metrics.

CTSH is the larger business by revenue, generating $21.4B annually — 4.2x G's $5.1B. Profitability is closely matched — net margins range from 10.9% (G) to 10.4% (CTSH).

MetricG logoGGenpact LimitedCTSH logoCTSHCognizant Technol…
RevenueTrailing 12 months$5.1B$21.4B
EBITDAEarnings before interest/tax$825M$3.9B
Net IncomeAfter-tax profit$552M$2.2B
Free Cash FlowCash after capex$732M$2.5B
Gross MarginGross profit ÷ Revenue+36.0%+32.1%
Operating MarginEBIT ÷ Revenue+14.8%+15.7%
Net MarginNet income ÷ Revenue+10.9%+10.4%
FCF MarginFCF ÷ Revenue+14.4%+11.5%
Rev. Growth (YoY)Latest quarter vs prior year+5.6%+5.8%
EPS Growth (YoY)Latest quarter vs prior year+3.8%+3.7%
G leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

G leads this category, winning 5 of 7 comparable metrics.

At 10.8x trailing earnings, G trades at a 4% valuation discount to CTSH's 11.3x P/E. Adjusting for growth (PEG ratio), G offers better value at 0.73x vs CTSH's 0.93x — a lower PEG means you pay less per unit of expected earnings growth.

MetricG logoGGenpact LimitedCTSH logoCTSHCognizant Technol…
Market CapShares × price$5.7B$24.3B
Enterprise ValueMkt cap + debt − cash$6.6B$24.0B
Trailing P/EPrice ÷ TTM EPS10.80x11.28x
Forward P/EPrice ÷ next-FY EPS est.8.41x9.03x
PEG RatioP/E ÷ EPS growth rate0.73x0.93x
EV / EBITDAEnterprise value multiple7.78x5.88x
Price / SalesMarket cap ÷ Revenue1.13x1.15x
Price / BookPrice ÷ Book value/share2.34x1.65x
Price / FCFMarket cap ÷ FCF7.81x9.37x
G leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

CTSH leads this category, winning 8 of 9 comparable metrics.

G delivers a 21.8% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $15 for CTSH. CTSH carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to G's 0.69x. On the Piotroski fundamental quality scale (0–9), CTSH scores 6/9 vs G's 5/9, reflecting solid financial health.

MetricG logoGGenpact LimitedCTSH logoCTSHCognizant Technol…
ROE (TTM)Return on equity+21.8%+14.8%
ROA (TTM)Return on assets+10.3%+10.9%
ROICReturn on invested capital+17.2%+18.7%
ROCEReturn on capital employed+18.4%+21.1%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage0.69x0.10x
Net DebtTotal debt minus cash$911M-$326M
Cash & Equiv.Liquid assets$854M$1.9B
Total DebtShort + long-term debt$1.8B$1.6B
Interest CoverageEBIT ÷ Interest expense12.08x107.78x
CTSH leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

G leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in G five years ago would be worth $7,785 today (with dividends reinvested), compared to $7,596 for CTSH. Over the past 12 months, G leads with a -30.6% total return vs CTSH's -32.3%. The 3-year compound annual growth rate (CAGR) favors G at -3.1% vs CTSH's -3.7% — a key indicator of consistent wealth creation.

MetricG logoGGenpact LimitedCTSH logoCTSHCognizant Technol…
YTD ReturnYear-to-date-26.0%-36.4%
1-Year ReturnPast 12 months-30.6%-32.3%
3-Year ReturnCumulative with dividends-9.1%-10.8%
5-Year ReturnCumulative with dividends-22.2%-24.0%
10-Year ReturnCumulative with dividends+41.3%-0.5%
CAGR (3Y)Annualised 3-year return-3.1%-3.7%
G leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

G leads this category, winning 2 of 2 comparable metrics.

G is the less volatile stock with a 0.67 beta — it tends to amplify market swings less than CTSH's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. G currently trades 67.3% from its 52-week high vs CTSH's 59.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricG logoGGenpact LimitedCTSH logoCTSHCognizant Technol…
Beta (5Y)Sensitivity to S&P 5000.67x0.75x
52-Week HighHighest price in past year$50.24$87.03
52-Week LowLowest price in past year$33.12$50.81
% of 52W HighCurrent price vs 52-week peak+67.3%+59.0%
RSI (14)Momentum oscillator 0–10037.024.7
Avg Volume (50D)Average daily shares traded2.3M6.0M
G leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CTSH leads this category, winning 2 of 2 comparable metrics.

Wall Street rates G as "Hold" and CTSH as "Hold". Consensus price targets imply 62.3% upside for CTSH (target: $83) vs 36.1% for G (target: $46). For income investors, CTSH offers the higher dividend yield at 2.47% vs G's 1.97%.

MetricG logoGGenpact LimitedCTSH logoCTSHCognizant Technol…
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$46.00$83.33
# AnalystsCovering analysts3951
Dividend YieldAnnual dividend ÷ price+2.0%+2.5%
Dividend StreakConsecutive years of raises89
Dividend / ShareAnnual DPS$0.67$1.27
Buyback YieldShare repurchases ÷ mkt cap+4.9%+5.7%
CTSH leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

G leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). CTSH leads in 2 (Profitability & Efficiency, Analyst Outlook).

Best OverallGenpact Limited (G)Leads 4 of 6 categories
Loading custom metrics...

G vs CTSH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is G or CTSH a better buy right now?

For growth investors, Cognizant Technology Solutions Corporation (CTSH) is the stronger pick with 7.

0% revenue growth year-over-year, versus 6. 6% for Genpact Limited (G). Genpact Limited (G) offers the better valuation at 10. 8x trailing P/E (8. 4x forward), making it the more compelling value choice. Analysts rate Genpact Limited (G) a "Hold" — based on 39 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — G or CTSH?

On trailing P/E, Genpact Limited (G) is the cheapest at 10.

8x versus Cognizant Technology Solutions Corporation at 11. 3x. On forward P/E, Genpact Limited is actually cheaper at 8. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Genpact Limited wins at 0. 57x versus Cognizant Technology Solutions Corporation's 0. 75x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — G or CTSH?

Over the past 5 years, Genpact Limited (G) delivered a total return of -22.

2%, compared to -24. 0% for Cognizant Technology Solutions Corporation (CTSH). Over 10 years, the gap is even starker: G returned +41. 3% versus CTSH's -0. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — G or CTSH?

By beta (market sensitivity over 5 years), Genpact Limited (G) is the lower-risk stock at 0.

67β versus Cognizant Technology Solutions Corporation's 0. 75β — meaning CTSH is approximately 12% more volatile than G relative to the S&P 500. On balance sheet safety, Cognizant Technology Solutions Corporation (CTSH) carries a lower debt/equity ratio of 10% versus 69% for Genpact Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — G or CTSH?

By revenue growth (latest reported year), Cognizant Technology Solutions Corporation (CTSH) is pulling ahead at 7.

0% versus 6. 6% for Genpact Limited (G). On earnings-per-share growth, the picture is similar: Genpact Limited grew EPS 9. 8% year-over-year, compared to 0. 9% for Cognizant Technology Solutions Corporation. Over a 3-year CAGR, G leads at 5. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — G or CTSH?

Genpact Limited (G) is the more profitable company, earning 10.

9% net margin versus 10. 6% for Cognizant Technology Solutions Corporation — meaning it keeps 10. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTSH leads at 16. 7% versus 15. 0% for G. At the gross margin level — before operating expenses — G leads at 35. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is G or CTSH more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Genpact Limited (G) is the more undervalued stock at a PEG of 0. 57x versus Cognizant Technology Solutions Corporation's 0. 75x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Genpact Limited (G) trades at 8. 4x forward P/E versus 9. 0x for Cognizant Technology Solutions Corporation — 0. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTSH: 62. 3% to $83. 33.

08

Which pays a better dividend — G or CTSH?

All stocks in this comparison pay dividends.

Cognizant Technology Solutions Corporation (CTSH) offers the highest yield at 2. 5%, versus 2. 0% for Genpact Limited (G).

09

Is G or CTSH better for a retirement portfolio?

For long-horizon retirement investors, Genpact Limited (G) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

67), 2. 0% yield). Both have compounded well over 10 years (G: +41. 3%, CTSH: -0. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between G and CTSH?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

G

Income & Dividend Stock

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Stocks Like

CTSH

Income & Dividend Stock

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform G and CTSH on the metrics below

Revenue Growth>
%
(G: 5.6% · CTSH: 5.8%)
Net Margin>
%
(G: 10.9% · CTSH: 10.4%)
P/E Ratio<
x
(G: 10.8x · CTSH: 11.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.